Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ABPNASDAQ:EDSANASDAQ:FLGCNASDAQ:IMCC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABPAbpro$0.21-7.8%$0.30$0.15▼$13.00$11.07M-0.015.71 million shs2.58 million shsEDSAEdesa Biotech$1.96-2.5%$2.28$1.55▼$5.59$14.12M0.55490,386 shs12,991 shsFLGCFlora Growth$0.70+3.2%$0.59$0.42▼$2.11$15.84M2.01274,833 shs61,904 shsIMCCIM Cannabis$1.91+8.5%$1.59$1.29▼$4.49$4.26M1.136,971 shs52,342 shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABPAbpro-7.83%-7.83%-34.61%-74.67%+21,199,900.00%EDSAEdesa Biotech-2.49%-3.45%-17.26%-17.65%-57.11%FLGCFlora Growth+3.24%+3.88%+27.61%-19.30%-43.84%IMCCIM Cannabis+7.30%+15.06%+24.43%-7.77%-49.15%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationABPAbproN/AN/AN/AN/AN/AN/AN/AN/AEDSAEdesa Biotech2.6057 of 5 stars3.55.00.00.00.91.70.6FLGCFlora Growth2.4836 of 5 stars3.35.00.00.00.80.81.3IMCCIM CannabisN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceABPAbpro 3.00Buy$4.001,786.79% UpsideEDSAEdesa Biotech 3.00Buy$21.00971.43% UpsideFLGCFlora Growth 2.50Moderate Buy$4.00469.80% UpsideIMCCIM Cannabis 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest IMCC, FLGC, ABP, and EDSA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/13/2025EDSAEdesa BiotechHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$21.00 ➝ $21.002/24/2025ABPAbproMaxim GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$4.00(Data available from 5/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookABPAbpro$183K60.49N/AN/AN/A∞EDSAEdesa BiotechN/AN/AN/AN/A$0.18 per shareN/AFLGCFlora Growth$53.26M0.30N/AN/A$0.78 per share0.90IMCCIM Cannabis$54.03M0.08N/AN/A$4.55 per share0.42Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateABPAbproN/AN/A0.00∞N/AN/AN/AN/AN/AEDSAEdesa Biotech-$6.17M-$1.59N/AN/AN/AN/A-233.69%-124.14%8/8/2025 (Estimated)FLGCFlora Growth-$57.04M-$0.98N/AN/AN/A-30.99%-268.17%-57.51%8/11/2025 (Estimated)IMCCIM Cannabis-$7.04M-$0.64N/AN/AN/A-25.55%-129.86%-23.63%8/12/2025 (Estimated)Latest IMCC, FLGC, ABP, and EDSA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2025N/AABPAbproN/A-$0.08N/A-$0.08N/AN/A5/15/2025Q1 2025IMCCIM Cannabis-$0.2540$0.06+$0.3140$0.06$11.45 million$8.69 million5/14/2025Q2 2025EDSAEdesa Biotech-$0.30-$0.30N/A-$0.30N/AN/A5/13/2025Q1 2025FLGCFlora Growth-$0.01-$0.04-$0.03-$0.04$14.79 million$11.79 million3/31/2025Q4 2024IMCCIM Cannabis-$0.39-$0.23+$0.16-$0.23$14.48 million$9.27 million3/24/2025Q4 2024FLGCFlora Growth-$0.11-$0.42-$0.31-$0.45$13.55 million$13.33 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthABPAbproN/AN/AN/AN/AN/AEDSAEdesa BiotechN/AN/AN/AN/AN/AFLGCFlora GrowthN/AN/AN/AN/AN/AIMCCIM CannabisN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioABPAbproN/AN/AN/AEDSAEdesa BiotechN/A1.090.91FLGCFlora Growth0.431.020.64IMCCIM Cannabis0.100.700.59Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipABPAbpro23.30%EDSAEdesa Biotech5.50%FLGCFlora Growth36.01%IMCCIM Cannabis7.68%Insider OwnershipCompanyInsider OwnershipABPAbpro20.80%EDSAEdesa Biotech22.60%FLGCFlora Growth12.56%IMCCIM Cannabis5.91%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableABPAbpro1552.22 million4.57 millionN/AEDSAEdesa Biotech207.02 million2.60 millionNot OptionableFLGCFlora Growth28022.57 million12.55 millionNot OptionableIMCCIM Cannabis3402.23 million2.10 millionNot OptionableIMCC, FLGC, ABP, and EDSA HeadlinesRecent News About These CompaniesIM Cannabis Corp. (IMCC) Q1 2025 Earnings Call TranscriptMay 15, 2025 | seekingalpha.comIM Cannabis Reports First Quarter Financial ResultsMay 15, 2025 | prnewswire.comIM Cannabis Announces Filing of Information Circular for Upcoming Annual General and Special Meeting and Provides Additional Information on the Focus TransactionMay 7, 2025 | prnewswire.comIM Cannabis to Report First Quarter 2025 Financial Results on Thursday, May 15th at 9:00am ETMay 6, 2025 | prnewswire.comIM Cannabis Provides Corporate UpdatesApril 11, 2025 | prnewswire.comIM Cannabis 2024 net loss ticks up despite successful cost-cutting initiativesMarch 31, 2025 | greenmarketreport.comIM Cannabis Corp. (IMCC) Q4 2024 Earnings Call TranscriptMarch 31, 2025 | seekingalpha.comIM Cannabis Reports Fourth Quarter and Full Year 2024 Financial ResultsMarch 31, 2025 | prnewswire.comIM Cannabis to Report Fourth Quarter and Full Year 2024 Financial Results on Monday, March 31 2025 at 9:00am ETMarch 20, 2025 | prnewswire.comIM Cannabis Announces Change of AuditorsJanuary 17, 2025 | prnewswire.comIM Cannabis Corp Raises Funds Amid Global ChallengesDecember 5, 2024 | markets.businessinsider.comIM Cannabis Corp. (IMCC) Q3 2024 Earnings Call TranscriptNovember 14, 2024 | seekingalpha.comIM Cannabis Reports Third Quarter Financial ResultsNovember 14, 2024 | prnewswire.comIM Cannabis to Report Third Quarter 2024 Financial Results on Thursday, November 14th at 9:00am ETNovember 6, 2024 | prnewswire.comIM Cannabis announces $1.6 million private placement to repay loanOctober 10, 2024 | mjbizdaily.comIM Cannabis Announces up to US$1,613,000 Private Placement Offering Led by ManagementOctober 4, 2024 | prnewswire.comIMC Germany Announces Outstanding Preliminary Q3, 2024 Performance with 50% Growth Over Q2October 2, 2024 | prnewswire.comIM 29 would legalize recreational marijuana in SDSeptember 17, 2024 | msn.comIM Cannabis appoints Shmulik Arbel to board of directorsSeptember 11, 2024 | canadianmanufacturing.comIM Cannabis Corp.: IM Cannabis Announces Appointment of Shmulik Arbel to Board of DirectorsSeptember 11, 2024 | finanznachrichten.deNew MarketBeat Followers Over TimeMedia Sentiment Over TimeIMCC, FLGC, ABP, and EDSA Company DescriptionsAbpro NASDAQ:ABP$0.21 -0.02 (-7.83%) As of 05/23/2025 04:00 PM EasternAbpro Holdings Inc. is a biotechnology company. The company's mission is to improve the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies. Abpro Holdings Inc., formerly known as Atlantic Coastal Acquisition Corp. II, is based in WOBURN, Mass.Edesa Biotech NASDAQ:EDSA$1.96 -0.05 (-2.49%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$1.99 +0.03 (+1.53%) As of 05/23/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in Covid-19 patients; and EB01, a topical vanishing cream containing non-steroidal anti-inflammatory compound that has completed Phase 2b clinical study to treat chronic allergic contact dermatitis. The company also develops EB02, an extension of secretory phospholipase 2 anti-inflammatory cream for treating erythema, swelling, and exudation associated with hemorrhoids disease; and EB06, an anti- chemokine ligand 10 (CXCL10) monoclonal antibody in vitiligo. It has a collaboration agreement with NovImmune SA to develop monoclonal antibodies targeting products containing toll-like receptor 4 and CXCL10 for therapeutic, prophylactic, and diagnostic applications in humans and animals; and Yissum Research Development Company for the development of products for therapeutic, prophylactic, and diagnostic uses in topical dermal and anorectal applications, as well as for the use in dermatologic and gastrointestinal conditions. The company was founded in 2015 and is headquartered in Markham, Canada.Flora Growth NASDAQ:FLGC$0.70 +0.02 (+3.24%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$0.70 -0.01 (-0.85%) As of 05/23/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products. It also offers food and beverage, nutraceuticals, cannabis accessories and technology, personal care, and wellness; cannabidiol (CBD) derived products, such as gummies, topicals, tinctures, and vape products; cannabis consumption accessories, personal storage, and travel accessories for the vape and dry herbs. In addition, the company manufactures and distributes pharmaceutical goods and medical cannabis products to treat a variety of health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. The company sells its products under the JustCBD, Vessel, and Phatebo brands. Flora Growth Corp. was incorporated in 2019 and is based in Fort Lauderdale, Florida.IM Cannabis NASDAQ:IMCC$1.91 +0.15 (+8.52%) Closing price 05/23/2025 03:57 PM EasternExtended Trading$1.91 +0.00 (+0.05%) As of 05/23/2025 07:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands. The company serves medical patients. IM Cannabis Corp. is headquartered in Tel Aviv, Israel. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/19 - 05/23 Trade Desk Silences Critics; Recovery Looks Poised to Continue Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH Stock Turbulence for Joby Shares: What's Behind the Recent Dip? Pfizer's 7.5% Dividend: Income Haven or House of Cards? TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain These ETFs Provide Easy Exposure to Growing International Markets Advance Auto Parts Jumps on Surprise Earnings Beat Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
